Pieris Pharmaceuticals (PIRS) EBITDA (2015 - 2024)
Pieris Pharmaceuticals (PIRS) EBITDA from Jun 30, 2015 to Sep 30, 2024. The TTM Pieris Pharmaceuticals (PIRS) EBITDA is $3.66M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Annual EBITDA change of Pieris Pharmaceuticals (PIRS)
| Year | EBITDA | Change |
|---|---|---|
| 2024 | -$9.73M | -18.03% |
| 2023 | -$12M | -70.84% |
| 2022 | -$41M | -17.56% |
| 2021 | -$49M | +55.30% |
| 2020 | -$32M | +19.87% |
| 2019 | -$27M | -12.36% |
| 2018 | -$30M | +112.80% |
| 2017 | -$14M | -36.52% |
| 2016 | -$22M | +67.54% |
| 2015 | -$13M | N/A |